Goldman Sachs’s LENZ Therapeutics LENZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.68M Sell
183,756
-74,186
-29% -$1.04M ﹤0.01% 4682
2025
Q4
$4.13M Buy
257,942
+216,666
+525% +$6.32M ﹤0.01% 3924
2025
Q3
$1.92M Buy
+41,276
New +$1.52M ﹤0.01% 4520
2025
Q2
Sell
-22,933
Closed -$590K 6500
2025
Q1
$590K Sell
22,933
-26,853
-54% -$661K ﹤0.01% 5086
2024
Q4
$1.44M Buy
49,786
+16,732
+51% +$510K ﹤0.01% 4561
2024
Q3
$785K Buy
33,054
+19,831
+150% +$440K ﹤0.01% 4802
2024
Q2
$229K Buy
+13,223
New +$231K ﹤0.01% 5202
2024
Q1
Sell
-4,077
Closed -$74.8K 5939
2023
Q4
$74.8K Sell
4,077
-749
-16% -$12.4K ﹤0.01% 5335
2023
Q3
$83.8K Sell
4,826
-127
-3% -$2.21K ﹤0.01% 5210
2023
Q2
$90.2K Buy
4,953
+3,070
+163% +$61.3K ﹤0.01% 5375
2023
Q1
$32.3K Sell
1,883
-2,203
-54% -$35.6K ﹤0.01% 5615
2022
Q4
$95K Sell
4,086
-31,876
-89% -$739K ﹤0.01% 5489
2022
Q3
$798K Sell
35,962
-23,764
-40% -$566K ﹤0.01% 4673
2022
Q2
$1.15M Buy
59,726
+54,399
+1,021% +$1.21M ﹤0.01% 4507
2022
Q1
$190K Buy
5,327
+2,485
+87% +$155K ﹤0.01% 5909
2021
Q4
$247K Sell
2,842
-7,745
-73% -$642K ﹤0.01% 5780
2021
Q3
$1.22M Sell
10,587
-28,617
-73% -$4.24M ﹤0.01% 4599
2021
Q2
$8.43M Buy
+39,204
New +$6.83M ﹤0.01% 2858

Other funds holding LENZ